Clinical Trial

A Study on the Relationship Between Individualized Low Voltage Regions in Left Atrium and the Mechanism of Atrial Fibrillation in Persistent Atrial Fibrillation Under Ultra-High-Resolution Mapping

Study acronym: ILVRA-PAFM-UAH
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2024 (before its estimated April 5, 2025 completion). Its status may not reflect the trial's current state.
Summary
The latest OCTARAY multi-electrode mapping catheter and TUREref technology were used to perform ultra-high precision mapping on the left atrial and left atrial auricle of persistent atrial fibrillation in the condition of sinus rhythm and atrial fibrillation respectively, and the density and accuracy of potential were significantly improved. According to the mapping results, the numerical calculation of the personalized low voltage region was carried out, and the personalized ablation route was designed according to the low voltage region.
Trial Details
NCT Number NCT06694610
Lead Sponsor The Third People's Hospital of Chengdu
Conditions Atrial Fibrillation Recurrent
Enrollment 120 participants
Start Date 2024-11-15
Primary Completion 2025-04-05 (estimated)
Study Completion 2026-04-05 (estimated)
Updated on ClinicalTrials.gov 2024-11-19